Founded in DE 2014, VUNO is a team of machine learning experts from Samsung Advanced Institute of Technology. With world's fastest gpu-based deep learning library 'VUNO-Net', VUNO provides intelligent solutions for vision tasks including image classification, object detection, scene understanding and contents-based image retrieval. Currently, VUNO is building medical image analysis software 'VUNO-Med', designed to help doctors to make faster, more accurate and consistent diagnosis. VUNO plans to build partnership with several top tier hospitals in Korea.
Location: South Korea, Seoul
Employees: 51-200
Phone: +82 2-515-6646
Founded date: 2014
Investors 3
| Date | Name | Website |
| - | BonAngels ... | bonangels.... |
| 12.01.2023 | Korea Inve... | partners.k... |
| - | SBI Invest... | sbik.co.kr |
Mentions in press and media 13
| Date | Title | Description |
| 13.11.2025 | Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth | - 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarte... |
| 29.10.2025 | VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe | - Strategic MOU enhances market access and extends reach to over 900 hospitals across the region SEOUL, South Korea, Oct. 29, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced today that it has signed a strategic Memora... |
| 26.05.2025 | VUNO Showcases DeepCARS® at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction | – Company engages U.S. critical care professionals with data-driven early warning solution MARLBOROUGH, Mass., May 26, 2025 /PRNewswire/ -- VUNO, a global medical AI company, presented its flagship solution VUNO Med®–DeepCARS® at the 2025 N... |
| 12.05.2025 | VUNO's AI-Powered Cardiac Arrest Risk Management System Earns CE MDR and UKCA Certifications | Early Regulatory Approval Accelerates Expansion Plans in Europe and the Middle East SEOUL, South Korea, May 12, 2025 /PRNewswire/ -- VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arres... |
| 17.06.2024 | VUNO PRESENTS CUTTING-EDGE AI BRAIN TECHNOLOGY AT AAIC - ANALYZING MRI SCANS IN | Potential partners are invited to explore collaboration opportunities with VUNO Med®-DeepBrain®, a highly accurate AI solution for research and clinical settings. MARLBOROUGH, Mass., June 17, 2024 /PRNewswire/ -- VUNO—acclaimed as a pioneer... |
| 23.10.2023 | VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain® | SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company has received 510(k) clearance from the Food and Drug Administration (FDA) for its AI-powered brain quantification device, VUNO Med®-DeepBrain®. VUN... |
| 25.11.2022 | VUNO Showcases their AI Solutions and Research Results at RSNA 2022 | SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society of North America 2022 (RSNA 2022). This year, VUNO wi... |
| 08.10.2021 | VUNO Signs Another Deal With Samsung Electronics To Incorporate AI-Assisted Solutions Into Samsung’s Premium Ceiling Type Digital Radiography System | South Korean artificial intelligence (AI) developer, VUNO Inc., announced that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO’s artificial intelligence-driven chest X-ray diag... |
| 05.10.2021 | VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung's Premium Ceiling Type Digital Radiography System | SEOUL, South Korea, Oct. 5, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed... |
| 24.08.2021 | MFDS Greenlights VUNO Med(R)-DeepCARS™, AI Medical Device for Cardiac Arrest Prediction | South Korean artificial intelligence (AI) developer, VUNO Inc. announced that it has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) for its VUNO Med®–DeepCARS™, an AI medical device for cardiac arrest predicti... |
Show more